IRONWOOD PHARMACEUTICALS INC
IRWDNASDAQ🏆 #2748 by market capEarnings Oct 29US Equity
$4.17▲ $0.05 (+1.09%)
Market closed · at closeTrack IRWD
Get earnings, price moves & breaking news on Telegram
24h▲ 1.1%
7d▼ 2.2%
14d▼ 0.1%
30d▼ 1.5%
ytd▲ 24.1%
1y▲ 215.9%
🏦Market Cap
$686M
Small Cap
📈Revenue Growth (YoY)
-15.7%
Declining
📊Gross Margin
99.8%
High
💵FCF Margin
47.7%
Strong
⚖️P/S Ratio
1.8x
Cheap
Otter Score
76
Good
IRONWOOD PHARMACEUTICALS INC
IRWDAnalyst Ratings
Price
$4.17
Total
30
Raised
7
Lowered
5
Avg PT
$6.68
H / L
$18 / $1
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Citizens | Reiterated | Market Outperform | 2026-02-26 | — | — |
Wells Fargo | Reiterated | Equal Weight | 2026-01-05 | $5.00 | +19.90% |
Jefferies | Downgraded | Buy → Hold | 2025-04-15 | $3.70 | −11.30% |
Leerink Partners | Reiterated | Market Perform | 2025-04-14 | $1.00 | −76.00% |
JMP Securities | Reiterated | Market Outperform | 2025-01-30 | — | — |
Craig-Hallum | Reiterated | Buy | 2025-01-22 | $5.70 | +36.70% |
Piper Sandler | Reiterated | Overweight | 2024-02-16 | $18.00 | +331.70% |
Morgan Stanley | Reiterated | Equal Weight | 2021-10-12 | — | — |
Credit Suisse | Reiterated | Neutral | 2020-11-06 | — | — |
HC Wainwright & Co. | Reiterated | Neutral | 2020-05-11 | — | — |
H.C. Wainwright | Upgraded | Sell → Neutral | 2019-02-25 | — | — |
JP Morgan | Upgraded | Underweight → Neutral | 2019-01-24 | — | — |
Cowen & Co. | Downgraded | Outperform → Market Perform | 2018-07-18 | — | — |
Barclays | Reiterated | Equal Weight | 2018-05-03 | — | — |
Mizuho | Upgraded | Neutral → Buy | 2018-05-02 | — | — |
B of A Securities | Downgraded | Buy → Underperform | 2018-01-05 | — | — |
Bank of America | Downgraded | Buy → Underperform | 2018-01-05 | — | — |
Goldman Sachs | Reiterated | Neutral | 2016-03-21 | — | — |
BTIG Research | Reiterated | Buy | 2015-12-11 | — | — |
Leerink Swann | Reiterated | Market Perform | 2015-05-05 | — | — |
Cantor Fitzgerald | Upgraded | Sell → Hold | 2015-02-06 | — | — |
Furey Research | Reiterated | Buy | 2014-07-09 | — | — |
Wallachbeth | Reiterated | Hold | 2014-06-18 | — | — |
BMO Capital | Reiterated | Market Perform → Perform | 2013-09-23 | — | — |
Janney Capital | Upgraded | Neutral → Buy | 2013-07-24 | — | — |
Janney Montgomery Scott | Upgraded | Neutral → Buy | 2013-07-24 | — | — |
Wedbush | Upgraded | Underperform → Neutral | 2013-05-30 | — | — |
Aegis Capital | Reiterated | Buy | 2013-04-23 | — | — |
UBS | Downgraded | Neutral → Sell | 2013-01-16 | — | — |
Ladenburg Thalmann | Reiterated | Buy | 2012-05-01 | — | — |
Institution
Citizens
Reiterated · Market Outperform · 2026-02-26
—
—
Wells Fargo
Reiterated · Equal Weight · 2026-01-05
$5.00
+19.90%
Jefferies
Downgraded · Buy → Hold · 2025-04-15
$3.70
−11.30%
Leerink Partners
Reiterated · Market Perform · 2025-04-14
$1.00
−76.00%
JMP Securities
Reiterated · Market Outperform · 2025-01-30
—
—
Craig-Hallum
Reiterated · Buy · 2025-01-22
$5.70
+36.70%
Piper Sandler
Reiterated · Overweight · 2024-02-16
$18.00
+331.70%
Morgan Stanley
Reiterated · Equal Weight · 2021-10-12
—
—
Credit Suisse
Reiterated · Neutral · 2020-11-06
—
—
HC Wainwright & Co.
Reiterated · Neutral · 2020-05-11
—
—
H.C. Wainwright
Upgraded · Sell → Neutral · 2019-02-25
—
—
JP Morgan
Upgraded · Underweight → Neutral · 2019-01-24
—
—
Cowen & Co.
Downgraded · Outperform → Market Perform · 2018-07-18
—
—
Barclays
Reiterated · Equal Weight · 2018-05-03
—
—
Mizuho
Upgraded · Neutral → Buy · 2018-05-02
—
—
B of A Securities
Downgraded · Buy → Underperform · 2018-01-05
—
—
Bank of America
Downgraded · Buy → Underperform · 2018-01-05
—
—
Goldman Sachs
Reiterated · Neutral · 2016-03-21
—
—
BTIG Research
Reiterated · Buy · 2015-12-11
—
—
Leerink Swann
Reiterated · Market Perform · 2015-05-05
—
—
Cantor Fitzgerald
Upgraded · Sell → Hold · 2015-02-06
—
—
Furey Research
Reiterated · Buy · 2014-07-09
—
—
Wallachbeth
Reiterated · Hold · 2014-06-18
—
—
BMO Capital
Reiterated · Market Perform → Perform · 2013-09-23
—
—
Janney Capital
Upgraded · Neutral → Buy · 2013-07-24
—
—
Janney Montgomery Scott
Upgraded · Neutral → Buy · 2013-07-24
—
—
Wedbush
Upgraded · Underperform → Neutral · 2013-05-30
—
—
Aegis Capital
Reiterated · Buy · 2013-04-23
—
—
UBS
Downgraded · Neutral → Sell · 2013-01-16
—
—
Ladenburg Thalmann
Reiterated · Buy · 2012-05-01
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space